Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
China Isotope & Radiation Corp. ( (HK:1763) ) just unveiled an update.
China Isotope & Radiation Corporation has been recognized for its exemplary ESG practices, receiving the Outstanding China ESG Practice and ESG Pioneers Index (Top 100) awards at the ESG China Innovation Annual Conference 2025. The company’s focus on technological innovation and sustainable development has led to significant advancements in nuclear technology applications, contributing to economic, environmental, and social benefits while supporting China’s health initiatives.
The most recent analyst rating on (HK:1763) stock is a Buy with a HK$19.50 price target. To see the full list of analyst forecasts on China Isotope & Radiation Corp. stock, see the HK:1763 Stock Forecast page.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation operates in the nuclear technology industry, focusing on radiopharmaceuticals, nuclide preparation, and nuclear medical equipment. The company is committed to technological innovation and plays a significant role in promoting health in China through its nuclear medicine solutions.
Average Trading Volume: 290,926
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.57B
For an in-depth examination of 1763 stock, go to TipRanks’ Overview page.